Form 4 Filing for Serina Therapeutics, Inc.

This filing details a transaction by Venkatesan Jay, a director at Serina Therapeutics, Inc. (SER), on March 31, 2026. Jay acquired 7,553 shares of Common Stock at a price of $1.94 per share. These shares were issued as payment for accrued dividends on a Convertible Preferred Stock. Following this transaction, Jay directly owns 7,553 shares of Serina Therapeutics, Inc. common stock. The filing was signed on April 21, 2026.